Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
66
Frequently Asked Questions
What is Market Cap of Immuneering Corp - Ordinary Shares Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immuneering Corp - Ordinary Shares Class A market cap is $280.6M.
What is the 52-week high for Immuneering Corp - Ordinary Shares Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immuneering Corp - Ordinary Shares Class A 52 week high is $10.08 as of September 30, 2025.
What is the 52-week low for Immuneering Corp - Ordinary Shares Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immuneering Corp - Ordinary Shares Class A 52 week low is $1.10 as of September 30, 2025.
What is Immuneering Corp - Ordinary Shares Class A stock price today?
Immuneering Corp - Ordinary Shares Class A stock price today is $7.02.
What was Immuneering Corp - Ordinary Shares Class A stock price yesterday?
Immuneering Corp - Ordinary Shares Class A stock price yesterday was $6.75.
What is the PE ratio of Immuneering Corp - Ordinary Shares Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Immuneering Corp - Ordinary Shares Class A’s P/E ratio is -3.56.
What is the Price-to-Book ratio of Immuneering Corp - Ordinary Shares Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Immuneering Corp - Ordinary Shares Class A P/B ratio is 8.3949.
What is the 50-day moving average of Immuneering Corp - Ordinary Shares Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immuneering Corp - Ordinary Shares Class A 50-day moving average is $5.45.
How many employess does Immuneering Corp - Ordinary Shares Class A has?
Immuneering Corp - Ordinary Shares Class A has 66 employees.
IMRX Immuneering Corp